RVPH
Closed
Reviva Pharmaceuticals Holdings Inc.
0.3694
-0.0117 (-3.07%)
Last Update: 01 Jul 2025 23:02:00
Yesterday: 0.3811
Day's Range: 0.3604 - 0.3888
Send
sign up or login to leave a comment!
When Written:
4.64
Reviva Pharmaceuticals Holdings Inc. is a clinical-stage pharmaceutical company that focuses on developing and commercializing innovative therapies for diseases with unmet medical needs. The company's lead product candidate, RP5063, is a novel, oral, small molecule drug that targets multiple serotonin and dopamine receptors in the brain. RP5063 is being developed for the treatment of schizophrenia, bipolar disorder, and major depressive disorder. The company also has a pipeline of other product candidates in various stages of development for the treatment of other neurological and psychiatric disorders. Reviva Pharmaceuticals Holdings Inc. was founded in 2006 and is headquartered in San Francisco, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








